Icosavax, Inc.
Total Trades
38
Buys
2
Sells
30
Largest Trade
$1M+
Insiders
9
Institutional Funds
2
Inst. Value
$100K–$500K
Activist Filings
18
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Simpson Adam K. | CEO | EXERCISE | $15K–$50K | 15K | $1.04 | Feb 3, 2024 |
| Simpson Adam K. | CEO | SELL | $100K–$500K | 15K | $15.29 | Feb 3, 2024 |
| Simpson Adam K. | CEO | EXERCISE | $15K–$50K | 15K | $1.04 | Jan 4, 2024 |
| Simpson Adam K. | CEO | SELL | $100K–$500K | 15K | $15.67 | Jan 4, 2024 |
| Simpson Adam K. | CEO | EXERCISE | $100K–$500K | 166K | $1.36 | Dec 22, 2023 |
| Simpson Adam K. | CEO | SELL | $1M+ | 152K | $15.44 | Dec 22, 2023 |
| Russo Thomas Joseph | CFO | SELL | $100K–$500K | 15K | $15.46 | Dec 22, 2023 |
| Kanesa-thasan Niranjan | Chief Medical Offi… | SELL | $100K–$500K | 12K | $15.46 | Dec 22, 2023 |
| Cearley Cassia | Chief Business Off… | SELL | $100K–$500K | 8K | $15.46 | Dec 22, 2023 |
| Kanesa-thasan Niranjan | Chief Medical Offi… | SELL | $15K–$50K | 3K | $8.86 | Aug 2, 2023 |
| Simpson Adam K. | CEO | SELL | $100K–$500K | 12K | $8.86 | Aug 2, 2023 |
| Russo Thomas Joseph | CFO | SELL | $15K–$50K | 3K | $8.86 | Aug 2, 2023 |
| Cearley Cassia | Chief Business Off… | SELL | $15K–$50K | 2K | $8.86 | Aug 2, 2023 |
| Holtzman Douglas | Chief Scientific O… | EXERCISE | $15K–$50K | 16K | $1.04 | Jul 3, 2023 |
| Holtzman Douglas | Chief Scientific O… | SELL | $100K–$500K | 16K | $8.85 | Jul 3, 2023 |
| Cearley Cassia | Chief Business Off… | SELL | $100K–$500K | 10K | $10.00 | May 25, 2023 |
| Holtzman Douglas | Chief Scientific O… | SELL | $100K–$500K | 20K | $6.09 | Apr 5, 2023 |
| Holtzman Douglas | Chief Scientific O… | EXERCISE | $15K–$50K | 20K | $1.04 | Apr 5, 2023 |
| Cearley Cassia | Chief Business Off… | SELL | $15K–$50K | 5K | $7.75 | Mar 8, 2023 |
| Bekiroglu Elizabeth | General Counsel & … | SELL | $50K–$100K | 6K | $10.69 | Feb 16, 2023 |
| Simpson Adam K. | CEO | SELL | $50K–$100K | 8K | $10.69 | Feb 16, 2023 |
| Holtzman Douglas | Chief Scientific O… | SELL | $50K–$100K | 5K | $10.33 | Feb 16, 2023 |
| Russo Thomas Joseph | CFO | SELL | $15K–$50K | 2K | $10.69 | Feb 16, 2023 |
| Kanesa-thasan Niranjan | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.69 | Feb 16, 2023 |
| Cearley Cassia | Chief Business Off… | SELL | $15K–$50K | 2K | $10.69 | Feb 16, 2023 |
| Simpson Adam K. | CEO | SELL | $500K+ | 67K | $8.96 | Dec 24, 2022 |
| Simpson Adam K. | CEO | EXERCISE | $1K–$15K | 14K | $0.84 | Dec 24, 2022 |
| Holtzman Douglas | Chief Scientific O… | SELL | $100K–$500K | 20K | $11.14 | Dec 16, 2022 |
| Bekiroglu Elizabeth | General Counsel & … | SELL | $1K–$15K | 2K | $4.87 | Sep 9, 2022 |
| Simpson Adam K. | CEO | SELL | $50K–$100K | 11K | $6.75 | Aug 3, 2022 |
| Russo Thomas Joseph | CFO | SELL | $15K–$50K | 3K | $6.75 | Aug 3, 2022 |
| Holtzman Douglas | Chief Scientific O… | SELL | $50K–$100K | 10K | $6.67 | Aug 3, 2022 |
| Richardson Charles E | SVP | SELL | $1K–$15K | 2K | $6.75 | Aug 3, 2022 |
| Kanesa-thasan Niranjan | Chief Medical Offi… | SELL | $15K–$50K | 3K | $6.75 | Aug 3, 2022 |
| Cearley Cassia | Chief Business Off… | SELL | $1K–$15K | 2K | $6.75 | Aug 3, 2022 |
| MCDADE MARK | Director | BUY | $100K–$500K | 42K | $7.10 | Apr 5, 2022 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $500K+ | 184K | $4.54 | Mar 30, 2022 |
| Cearley Cassia | Chief Business Off… | SELL | $100K–$500K | 10K | $17.16 | Mar 9, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2023 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 15K | $100K–$500K | SH |
| Legal & General Group Plc | 2K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Qiming U.S. Healthcare Fund II, L.P.
SC 13D/A · Feb 21, 2024
0.0%
0 shares
SC 13D/A · Feb 21, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
0.5%
6 shares
Pentwater Capital Management LP
SC 13G · Feb 14, 2024
5.9%
3.0M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Feb 14, 2024
7.8%
3.9M shares
SC 13G · Feb 2, 2024
5.2%
2.6M shares
SC 13G/A · Jan 10, 2024
4.5%
2.2M shares
SC 13G · Jul 25, 2023
7.5%
3.7M shares
SC 13G · Jun 5, 2023
5.3%
6 shares
SC 13D/A · May 30, 2023
12.5%
6.0M shares
SC 13G/A · Feb 14, 2023
3.2%
1.3M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Jan 10, 2023
11.2%
4.5M shares
SC 13G · Jan 10, 2023
12.2%
4.9M shares
Qiming U.S. Healthcare Fund II, L.P.
SC 13D · Feb 28, 2022
9.0%
3.5M shares
SC 13G/A · Feb 10, 2022
7.0%
2.7M shares